Novo Nordisk wins China semaglutide patent ruling while India case falters
Danish drugmaker Novo Nordisk has secured a key legal victory in China over its blockbuster semaglutide drug, even as it suffered a judicial setback in India.Danish drugmaker Novo Nordisk has secured...To view the full article, register now.
Already a subscriber? Click here to view full article